Literature DB >> 18360815

Rho GTPase activation assays.

Stéphanie Pellegrin1, Harry Mellor.   

Abstract

The Rho GTPase family of signaling proteins controls a wide range of highly dynamic cellular processes. Activation of Rho GTPases can be investigated and quantified in cell extracts using so-called pull-down assays. Proteins that bind specifically to the activated form of the Rho GTPase are used to capture it onto a bead support. Western blotting of the captured samples with specific antibodies then allows for quantification of the level of Rho GTPase activation in the sample. This unit describes the techniques for preparing the reagents required for assays of RhoA, Rac, and Cdc42 and gives practical tips for the successful application of the assay in a range of situations. (c) 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360815     DOI: 10.1002/0471143030.cb1408s38

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  18 in total

1.  The Cdc42 guanine nucleotide exchange factor FGD6 coordinates cell polarity and endosomal membrane recycling in osteoclasts.

Authors:  Charlotte Steenblock; Tobias Heckel; Cornelia Czupalla; Ana Isabel Espírito Santo; Christian Niehage; Martin Sztacho; Bernard Hoflack
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

2.  Periodic propagating waves coordinate RhoGTPase network dynamics at the leading and trailing edges during cell migration.

Authors:  Alfonso Bolado-Carrancio; Oleksii S Rukhlenko; Elena Nikonova; Mikhail A Tsyganov; Anne Wheeler; Amaya Garcia-Munoz; Walter Kolch; Alex von Kriegsheim; Boris N Kholodenko
Journal:  Elife       Date:  2020-07-24       Impact factor: 8.140

3.  Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.

Authors:  Laurent O Mosnier; Ranjeet K Sinha; Laurent Burnier; Eveline A Bouwens; John H Griffin
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

4.  A luminescent oxygen channeling biosensor that measures small GTPase activation.

Authors:  Björn Niebel; Benjamin Weiche; Alan L Mueller; Dean Y Li; Nora Karnowski; Michael Famulok
Journal:  Chem Commun (Camb)       Date:  2011-05-31       Impact factor: 6.222

5.  Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma.

Authors:  Charlotte R Feddersen; Jacob L Schillo; Afshin Varzavand; Hayley R Vaughn; Lexy S Wadsworth; Andrew P Voigt; Eliot Y Zhu; Brooke M Jennings; Sarah A Mullen; Jeremy Bobera; Jesse D Riordan; Christopher S Stipp; Adam J Dupuy
Journal:  Cancer Res       Date:  2019-08-15       Impact factor: 12.701

6.  IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.

Authors:  Jamie McIntosh; Godwin Dennison; Jeff M P Holly; Caroline Jarrett; Alexandra Frankow; Emily J Foulstone; Zoe E Winters; Claire M Perks
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

7.  Galectin-3-induced cell spreading and motility relies on distinct signaling mechanisms compared to fibronectin.

Authors:  Shyam K More; Shubhada V Chiplunkar; Rajiv D Kalraiya
Journal:  Mol Cell Biochem       Date:  2016-04-29       Impact factor: 3.396

8.  The fic domain: regulation of cell signaling by adenylylation.

Authors:  Carolyn A Worby; Seema Mattoo; Robert P Kruger; Lynette B Corbeil; Antonius Koller; Juan C Mendez; Bereket Zekarias; Cheri Lazar; Jack E Dixon
Journal:  Mol Cell       Date:  2009-04-10       Impact factor: 17.970

9.  Cell type-specific Nogo-A gene ablation promotes axonal regeneration in the injured adult optic nerve.

Authors:  F Vajda; N Jordi; D Dalkara; S Joly; F Christ; B Tews; M E Schwab; V Pernet
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

10.  Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway.

Authors:  Kenneth C Loh; Weng-In Leong; Morgan E Carlson; Babak Oskouian; Ashok Kumar; Henrik Fyrst; Meng Zhang; Richard L Proia; Eric P Hoffman; Julie D Saba
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.